Millendo Therapeutics

Developer of immune-mediated targeted cancer therapies

placeAnn Arbor, Michigan, United States calendar_todayFounded 2012 groups30 employees language millendo.com

Registered entities

Investor mix

13 investors on record; lead investors include 5AM Ventures, Frazier Healthcare Partners, New Enterprise Associates; 1 has since exited.

Investor typeCountShare
Venture capital754%
Private equity323%
Bank & private debt18%
Other / undisclosed215%
Coming soon